Now or later: Health impacts of delaying single-dose HPV vaccine implementation in a high-burden setting.
Burger EA, Laprise JF, Sy S, Regan MC, Prem K, Jit M, Brisson M, Kim JJ.
Int J Cancer. 2022 May 05. PMID: 35512109
Faculty Administration
Jane J Kim
Other Positions
K.T. Li Professor of Health Economics
Health Policy and Management
Harvard T.H. Chan School of Public Health
Overview
Dr. Kim's research focuses on the development and application of mathematical modeling methods to evaluate health policy issues related to women's health. She has developed and used models to perform cost-effectiveness analyses of cervical cancer screening strategies in the U.S., Europe, Hong Kong, and less developed regions.
Her methodological interests include integrating different methods of operations research to inform health decision-making in low-resource settings, such as packaging health services at opportune moments and quantifying the impacts of budget and human resource constraints on program effectiveness and feasibility.
She has won awards for her presentations at annual meetings held by the Society for Medical Decision Making and the International Papillomavirus Society.
Dr. Kim holds a Master's degree in Health Policy and Management from the Harvard School of Public Health (2001) and a Ph.D. in Health Policy and Decision Sciences from Harvard University (2005).
Bibliography
Identifying a Single Optimal Integrated Cervical Cancer Prevention Policy in Norway: A Cost-Effectiveness Analysis.
Portnoy A, Pedersen K, Nygård M, Trogstad L, Kim JJ, Burger EA.
Med Decis Making. 2022 Mar 08. 272989X221082683. PMID: 35255741
Cost-Effectiveness of Early Intervention in Psychosis: A Modeling Study.
Sediqzadah S, Portnoy A, Kim JJ, Keshavan M, Pandya A.
Psychiatr Serv. 2022 Feb 23. appips202100161. PMID: 35193372
Impact of Delaying Effective and Cost-Effective Policy Decisions: An Example From Cervical Cancer Prevention in Norway.
Portnoy A, Nygård M, Trogstad L, Kim JJ, Burger EA.
MDM Policy Pract. 2022 Jan-Jun. 7(1):23814683211071093. PMID: 35024449
Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial.
Porras C, Sampson JN, Herrero R, Gail MH, Cortés B, Hildesheim A, Cyr J, Romero B, Schiller JT, Montero C, Pinto LA, Schussler J, Coronado K, Sierra MS, Kim JJ, Torres CM, Carvajal L, Wagner S, Campos NG, Ocampo R, Kemp TJ, Zuniga M, Lowy DR, Avila C, Chanock S, Castrillo A, Estrada Y, Barrientos G, Monge C, Oconitrillo MY, Kreimer AR.
Vaccine. 2022 01 03. 40(1):76-88. PMID: 34857420
Potential effectiveness of a therapeutic HPV intervention campaign in Uganda.
Spencer JC, Campos NG, Burger EA, Sy S, Kim JJ.
Int J Cancer. 2022 03 01. 150(5):847-855. PMID: 34741526
Switching clinic-based cervical cancer screening programs to human papillomavirus self-sampling: A cost-effectiveness analysis of vaccinated and unvaccinated Norwegian women.
Pedersen K, Portnoy A, Sy S, Hansen BT, Tropé A, Kim JJ, Burger EA.
Int J Cancer. 2022 02 01. 150(3):491-501. PMID: 34664271
Projections of human papillomavirus (HPV) vaccination impact in Ethiopia, India, Nigeria and Pakistan: a comparative modelling study.
Portnoy A, Abbas K, Sweet S, Kim JJ, Jit M.
BMJ Glob Health. 2021 11. 6(11). PMID: 34725040
Erratum: 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, Huh WK, Kim JJ, Moscicki AB, Nayar R, Saraiya M, Sawaya GF, Wentzensen N, Schiffman M.
J Low Genit Tract Dis. 2021 10 01. 25(4):330-331. PMID: 34542089
Cost-effectiveness analysis of the 2019 American Society for Colposcopy and Cervical Pathology Risk-Based Management Consensus Guidelines for the management of abnormal cervical cancer screening tests and cancer precursors.
Munshi VN, Perkins RB, Sy S, Kim JJ.
Am J Obstet Gynecol. 2022 02. 226(2):228.e1-228.e9. PMID: 34547295
News
Graduates from 2020 and 2021 welcomed back for in-person Convocation
More than 500 members of the Harvard T.H. Chan School of Public Health classes of 2020 and 2021 returned on May 28 for a special Convocation.
The power of global partnerships in public health
Harvard T.H. Chan School of Public Health's Convocation for the Class of 2022—the first in-person graduation to be held since 2019 due to the COVID-19 pandemic—celebrated the accomplishments of 633 graduates.
Frontlines Spring 2021
Quick updates about the latest public health news from across the School and beyond.
HPV vaccines for adults over age 26 may not be cost-effective
For immediate release: Thursday, March 11, 2021 Boston, MA – Vaccinating adults age 26 and older against the human papillomavirus (HPV)—the virus that causes more than 90% of cervical cancers as well as several other cancers—may not be…
Students perform at annual International Night—virtually
June 23, 2020 – Unnati Mehta twirled and leapt gracefully during two Indian dances—in front of an invisible audience. Mehta, a doctoral student at Harvard T.H. Chan School of Public Health, was among the many performers at the…
You must be logged in to post a comment.